subgroup of
drug)
→
ReceivesAction
→
approved for public use
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| new drug → be approved for → public use | 3 |
| negative | neutral | positive |
| 0.022 | 0.600 | 0.378 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 62.032 |